SCHEMBL8441972

SCHEMBL8441972

O=C1CSCN1CCCCl

nearest known ligand 0.49

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9560262 0.78 MGLL (0.43) MAPT
SCHEMBL3538727 0.72 ACHE (0.39)
SCHEMBL1787694 0.70
SCHEMBL11022521 0.69
SCHEMBL14370062 0.65 PIK3CD (0.47)
SCHEMBL2493043 0.65 PIK3CD (0.47)
SCHEMBL9825290 0.65 KMT2A (0.43)
SCHEMBL7609502 0.64 ALDH1A1 (0.32) MAPT
SCHEMBL3943706 0.64 L3MBTL1 (0.47)
SCHEMBL15884956 0.63 GAA (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5998452-A CARDIOVASCULAR DISORDERS CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 1999-12-07 US disclosed
EP-0799614-A1 REMEDY FOR ISCHEMIC DISEASES CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 1997-10-08 EP disclosed
EP-0203743-B1 OXOTHIAZOLIDINE COMPOUND FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1991-02-06 EP disclosed
US-4764514-A COGNITIONACTIVATORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-08-16 US disclosed
EP-0203743-A1 Oxothiazolidine compound FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-12-03 EP disclosed